What is GHRP-6?

GHRP-6 (Growth Hormone Releasing Peptide-6) is a synthetic hexapeptide from the GHRP peptide group, acting as an agonist of the ghrelin receptor GHS-R1a. In scientific research, this mechanism has been linked to stimulating growth hormone (GH) secretion, as well as a pronounced influence on appetite signals. In published data, GHRP-6 has been described as a stronger stimulator of GH secretion compared to Ipamorelin, but with lower selectivity, as it can also affect cortisol and prolactin levels under certain conditions. In research models, GHRP-6 has been considered in relation to muscle growth, tissue repair, and metabolic processes. Effects on anabolism, bone health, lipolysis, deep sleep, and appetite have also been observed.

Observations for GHRP-6

GHRP-6 is being investigated for its possible effects on:

• Stimulation of growth hormone - activation of GH pulses and changes in IGF-1 levels have been observed

• Anabolic effect on muscle mass and protein synthesis processes

• Improved recovery - investigated in relation to regeneration after physical exertion

• Joint and bone health - considered in relation to bone mineralization and connective tissue repair

• Influence on lipolytic processes and metabolic regulation

• Studies on GH secretion with aging

• In studies, a pronounced appetite-stimulating effect has been described, linked to the activation of ghrelin receptors

Administration and Dosage

In scientific literature, subcutaneous administration in the range of 100-300 μg daily, usually divided into 1-3 applications within research protocols, has been described.

For 5 mg + 3 ml bacteriostatic water:

Concentration = 1.67 mg/ml → 0.15 ml = 250 μg

For 10 mg + 3 ml bacteriostatic water:

Concentration = 3.3 mg/ml → 0.15 ml = 500 μg

Approximate values for 5 mg:

0.06 ml = 100 μg

0.12 ml = 200 μg

0.18 ml = 300 μg

0.24 ml = 400 μg

Approximate values for 10 mg:

0.06 ml = 200 μg

0.12 ml = 400 μg

0.18 ml = 600 μg

0.24 ml = 800 μg

Scientific Data

In scientific literature, GHRP-6 is among the most studied representatives of the Growth Hormone Releasing Peptides group. It has been described to stimulate endogenous growth hormone (GH) release in a dose-dependent manner, by activating GHS-R1a receptors and supporting the physiological pulsatile pattern of GH secretion.

GHRP-6 has shown the ability to increase GH and IGF-1 levels, while also being considered in relation to recovery processes, protein synthesis, and metabolic activity. A characteristic feature of this peptide is its pronounced effect on appetite, which is explained by the activation of ghrelin receptors and distinguishes it from other GHRP analogs.

In experimental models, it has been observed that GHRP-6 can have a neutral or minimal effect on cortisol and prolactin at moderate amounts, while at higher experimental levels these hormones may increase. This makes it a subject of interest in research on metabolic and anabolic processes, aging, and tissue regeneration.

Application in Sport

GHRP-6 is prohibited by WADA for use in professional sports, due to its potential role in:

• stimulating growth hormone secretion

• accelerating tissue recovery

• supporting muscle growth and strength

• reducing regeneration time after physical exertion

• increasing appetite and caloric intake

Possible Side Effects

Adverse reactions described in scientific literature are predominantly dose-dependent and may include:

• redness, sensitivity, or pain at the injection site

• increased appetite

• fluid retention

• fatigue or drowsiness

Less commonly reported:

• headache or dizziness

• increase in cortisol and prolactin at higher doses

The information is gathered and systematized from various scientific sources and studies. It serves solely for educational purposes and should not be used for the diagnosis, treatment, or prevention of diseases.